References
1. Lauring AS, Jones JO, Andino R. Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol. 2010;28(6):573–9.
2. Johnson RP, Desrosiers RC. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol.
1998;10(4):436–43.
3. Mills J, Desrosiers R, Rud E, Almond N. Live attenuated HIV vaccines: proposal for further research and development.
AIDS Res. Hum Retroviruses 2000;16:1453–61.
4. Whitney JB, Ruprecht RM. Live attenuated HIV vaccines: pitfalls and prospects. Curr Opin Infect Dis. 2004;17(1):17–26.
5. Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug KJ, et al. HIV vaccine design: insights from live attenuated
SIV vaccines. Nat Immunol. 2006;7(1):19–23.
6. Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live, attenuated SIV after mucosal
infection of neonatal macaques. Science. 1995;267:1820–5.
7. Baba TW, Liska V, Khimani AH, Ray NB, Dailey PJ, Penninck D, et al. Live attenuated, multiply deleted simian immunodeficiency
virus causes AIDS in infant and adult macaques. Nat Med. 1999;5:194–203.
8. Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C. A truncated form of Nef
selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication. J Virol.
2003;77(2):1245–56.
9. Whatmore AM, Cook N, Hall GA, Sharpe S, Rud EW, Cranage MP. Repair and evolution of nef in vivo modulates simian immunodeficiency
virus virulence. J Virol. 1995;69:5117–23.
10. Hofmann-Lehmann R, Vlasak J, Williams AL, Chenine AL, McClure HM, Anderson DC, O'Neil S, Ruprecht RM. Live attenuated,
nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS. 2003;24:17(2):157–66.
11. Churchill MJ, Rhodes DI, Learmont JC, Sullivan JS, Wesselingh SL, Cooke IR, Deacon NJ, Gorry PR. Longitudinal analysis
of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from
a single source. J Virol. 2006;80(2):1047–52.
12. Berkhout B, Verhoef K, van Wamel JLB, Back B. Genetic instability of live-attenuated HIV-1 vaccine strains. J Virol.
1999;73:1138–45.
13. Berkhout B, Paxton WA. HIV vaccine: it may take two to tango, but no party time yet. Retrovirol. 2009;6:88.
14. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, van Rompay KK, et al. A partially attenuated simian immunodeficiency
virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol. 1994;68:7021–9.
15. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, Desrosiers RC. Vaccine protection by a triple deletion mutant of simian
immuodeficiency virus. J Virol. 1996;70:3724–33.
16. Lifson JD, Rossio JL, Piatak M Jr., Parks T, Li L, Kiser R, et al. Role of CD8(+) lymphocytes in control of simian immunodeficiency
virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol. 2001;75(21):10187–99.
17. Evans DT, Bricker JE, Desrosiers RC. A novel approach for producing lentiviruses that are limited to a single cycle
of infection. J Virol. 2004;78(21):11715–25.
18. Evans DT, Bricker JE, Sanford HB, Lang S, Carville A, Richardson BA, et al. Immunization of macaques with single-cycle
simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge
with SIVmac239. J Virol. 2005;79(12):7707–20.
19. Falkensammer B, Rubner B, Hiltgartner A, Wilflingseder D, Stahl HC, Kuate S, et al. Role of complement and antibodies
in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient
viral vectors. Retrovirol. 2009;6:60.
20. Kuate S, Stahl-Hennig C, ten HP, Heeney J, Uberla K. Single-cycle immunodeficiency viruses provide strategies for uncoupling
in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines. Virol. 2003;313(2):653–62.
|
